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Abstract
Background: Individuals with severe mental illness (e.g., schizophrenia, bipolar disorder) die 10–25 years earlier than the
general population, primarily from premature cardiovascular disease (CVD). Contributing factors are complex, but include
systemic-related factors of poorly integrated primary care and mental health services. Although evidence-based models
exist for integrating mental health care into primary care settings, the evidence base for integrating medical care into
specialty mental health settings is limited. Such models are referred to as “reverse” integration. In this paper, we describe
the application of an implementation science framework in designing a model to improve CVD outcomes for individuals
with severe mental illness (SMI) who receive services in a community mental health setting.
Methods: Using principles from the theory of planned behavior, focus groups were conducted to understand
stakeholder perspectives of barriers to CVD risk factor screening and treatment identify potential target behaviors. We
then applied results to the overarching Behavior Change Wheel framework, a systematic and theory-driven approach that
incorporates the COM-B model (capability, opportunity, motivation, and behavior), to build an intervention to improve
CVD risk factor screening and treatment for people with SMI.
Results: Following a stepped approach from the Behavior Change Wheel framework, a model to deliver primary
preventive care for people that use community mental health settings as their de facto health home was developed.
The CRANIUM (cardiometabolic risk assessment and treatment through a novel integration model for underserved
populations with mental illness) model focuses on engaging community psychiatrists to expand their scope of practice
to become responsible for CVD risk, with significant clinical decision support.
Conclusion: The CRANIUM model was designed by integrating behavioral change theory and implementation theory.
CRANIUM is feasible to implement, is highly acceptable to, and targets provider behavior change, and is replicable and
efficient for helping to integrate primary preventive care services in community mental health settings. CRANIUM can
be scaled up to increase CVD preventive care delivery and ultimately improve health outcomes among people with
SMI served within a public mental health care system.
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Background
People with severe mental illness (SMI—e.g., schizophrenia,
bipolar disorder) die on average 25 years earlier than the
general population, most often from cardiovascular disease
(CVD) [1, 2]. Although CVD mortality in this population is
multifactorial, some risk is attributed to treatment with
antipsychotic medications [3]. In 2004, the American Dia-
betes Association and American Psychiatric Association
published metabolic screening guidelines for people taking
antipsychotic medications [4]. Although adherence to
screening guidelines improves care in the general popula-
tion [5], a review of 48 studies on metabolic monitoring of
people taking antipsychotic medications found screening to
be consistently low [6]. Leading experts agree that the geo-
graphic, electronic, cultural, and fiscal separation of primary
care and mental health within most US healthcare systems
contributes to poor quality of medical care in general for
this vulnerable population [3, 7]. Notably, people with SMI
are receptive to treatment of metabolic disorders when
available as there is evidence that adherence to
hypoglycemic medications is better among diabetes patients
with schizophrenia than those without [8–10]. Given the
complexity of this problem, public mental health adminis-
trators request cost-effective, evidence-based interventions
that can be feasibly implemented and sustained to improve
care for this vulnerable population [3, 11].
Fortunately, integration of behavioral and physical health
care has become a significant focus of recent reforms [12].
This trend is critical given that behavioral health conditions
account for nearly 25% of all disabilities worldwide [13],
mental and physical health disorders are strongly associated
[14], and patients experiencing comorbid behavioral health
conditions and medical disabilities are costly to the health
care system [15], and most people with mental illness lack
formal treatment [16]. Collaborative Care is an evidence-
based model for integrating mental health, behavioral
health, and substance use services with primary care set-
tings [17]. This team-based model has four main principles:
(1) patient-centered team care (a primary care provider,
behavioral health care manager, and consulting psych-
iatrist), (2) population-based care (patient registry), (3)
measurement-based treatment to target (serial PHQ-9
screening), and (4) evidence-based care (guideline-recom-
mended psychotherapies and pharmacological management
of depression). In a recent Cochrane review, Collaborative
Care was reported to demonstrate efficacy and cost-
effectiveness in over 80 randomized controlled trials [18].
Unfortunately, structural dysfunctions in the US public
healthcare system—where mental health and primary care
exist in separate silos—are major contributors to disparities
along the health care continuum [19, 20]. Although CVD
risk factor screening could occur in primary care, people
with SMI have significantly lower utilization of primary care
than the general population [21–24]. However, almost half
of the people with SMI regularly access community mental
health services, making these settings the de-facto “health
home” for 3.5 million people with SMI [25–28]. A health
home is a team-based clinical approach that aims to im-
prove outcomes and experience of care, as well as to con-
trol costs, through coordinated care and linkages to
community supports for individuals with multiple chronic
conditions [29]. “Reverse integration”—provision of primary
care in community mental health clinics— initiatives are
reasonable considering the parallel in primary care [18].
Four arguments for screening and treating depression in
primary care are as follows: (1) major depression is com-
mon in general medical settings [30], (2) people who are
depressed are likely to be receiving care from a primary
care provider [31], (3) depression treatment guidelines exist
[32], and (4) untreated depression is costly to society [33].
Parallel arguments justify screening and treatment in com-
munity mental health: (1) CVD risk factors (e.g., diabetes,
hypertension, dyslipidemia, smoking) are common among
people with SMI [20, 34, 35], (2) people with SMI receive
care in community mental health settings [25, 26], (3) treat-
ment guidelines for CVD risk factors exist [36–39], and (4)
untreated CVD risk factors are costly to society [40].
While several reverse integration models have been
proposed [23, 25, 41–45], Cochrane, RAND, and other sys-
tematic reviews have failed to identify sufficient evidence to
yet recommend any specific model [46–48]. Several excel-
lent NIH-funded investigators and SAMHSA-funded
administrators have been working hard to develop models
to improve the health care of people with SMI. For ex-
ample, investigators have conducted trials studying satellite
primary care clinics [23], peer-led medical disease self-
management [49–51], electronic reminders to providers or
patients [52], a clinical decision support program for
primary care providers treating people with SMI [53,
54], care coordination [23, 41–43, 45], provider edu-
cation [55], and other patient-centered approaches
[44, 47, 56–58]. None of these studies target provider
behavior by expanding the scope of practice of com-
munity psychiatrists.
While most experts agree in theory that a “behavioral
health home”—an integrated care model for people with se-
vere mental illness, based on the conceptual model of a
health home and located in community mental health set-
tings—would be the best approach for this population [59–
61], to our knowledge, no one has explicitly utilized imple-
mentation science methods to develop an effective and sus-
tainable model of care where psychiatrists take primary
responsibility for the medical care of their patients.
This paper describes the use of an implementation sci-
ence framework—the Behavior Change Wheel [62]—to de-
velop an integration of care model for people with SMI
served in community mental health settings. We chose this
model because our main target was changing psychiatrists’
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behavior so they would address primary preventative ser-
vices for people with SMI. Although the BCW framework
is not new, we believe that readers might benefit from an
applied and innovative example of in this unique setting.
To our knowledge, this study is innovative because the vast
majority of integration of care community programs have
not been using behavioral change theory approaches in the
development of their models [61].
Methods
Theoretical frameworks used to develop the model
To develop a model to improve the CVD risk factor screen-
ing and treatment of people with SMI served in community
mental health clinics, we decided to systematically ap-
proach the problem using a specific implementation sci-
ence framework to guide the process of the intervention
development. We wanted to use this systematic approach
so that the intervention we developed would be well
grounded in behavior change theory such that specific be-
havioral targets could be first identified and then addressed
with intervention components mapping to the targets. We
drew primarily on Michie and colleagues’ Behavior Change
Wheel (BCW) framework [62] and the associated and the
Theoretical Domains Framework (TDF) [63, 64], as well as
on, the Theory of Planned Behavior (TPB) [65]. The BCW
framework and TDF were chosen as they link identified be-
havioral targets with to intervention functions most likely
to bring about clinic- and provider-level change. The TPB
has been widely used in settings focusing on provider be-
haviors and was selected to complement the BCW and
TDF approaches for improving the understanding of behav-
ior change “targets” required to ensure that people with
SMI receive metabolic screenings and treatment at a com-
munity mental health clinic. This integrated approach to
exploring the barriers to delivery of a cardiometabolic
screening model to patients with SMI and subsequent
intervention development through multiple theoretical
lenses allows for us to understand in more depth how
intervention components ‘map back’ to several important
underlying theoretical constructs. For example, this
approach allows for a rich examination of the cognitively
oriented role of provider attitudes, as in the TPB, while at
the same time also being able to examine a wider range of
factors underlying the BCW approach, which includes a
greater focus on non-cognitive factors.
The BCW framework consists of a behavior system at
the hub with three critical components: capability, oppor-
tunity, and motivation (COM-B model) (see Fig. 1). Sur-
rounding the hub are nine intervention functions that aim
to address the deficits in one or more of these conditions.
A larger wheel surrounds the intervention functions and
consists of seven policy categories. These policy categories
are broader population-level strategies that enable the inter-
vention functions to occur.
The Theory of Planned Behavior (TPB) has been widely
used to understand social and health behaviors and to de-
velop interventions [65]. The TPB proposes that an individ-
ual’s intention to perform a behavior is the best predictor of
behavior and suggests that there are three immediate deter-
minants of intention. These include an individual’s attitude
regarding the targeted behavior, their subjective norm re-
garding the behavior, and their perceived behavioral control
over the behavior [65]. The TPB relates directly to the
COM-B model (capability, opportunity, and motivation are
the key ingredients of behavior change) in that motivation
is analogous to intention and is also further influenced by
social norms while capability is influenced by perceived be-
havioral control. Furthermore, studies suggest that this the-
ory has demonstrated success in improving various health
behaviors [66].
The TDF is related to the BCW and was created from
numerous behavior change theories, including the TPB,
through a consensus process [62–65]. The framework in-
cludes 14 domains: knowledge; skills; memory; attention
and decision processes; behavioral regulation; social role
and identity; beliefs about capabilities; optimism; beliefs
about consequences; intentions; goals; reinforcement;
emotion; environmental context and resources; and social
influences [47]. Each domain is related to a set of theoret-
ical constructs that was derived from existing theories of
behavior change [35]. Since each domain of the TDF
correlates to a BCW COM-B component, using the two
together allows for an expansion of the COM-B compo-
nents into very specific domains [67]. We chose BCW and
TDF instead of other implementation models (e.g., CFIR)
because of their strong emphasis on behavior change, and
the utilization of these framework in development of
several other interventions targeting health care profes-
sionals’ behavior [68–76]. There are few examples of using
the selected implementation science frameworks for
integration of multiple components of care in a context of
co-management across disciplines. For example, in a
recent systematic review of changing healthcare profes-
sionals’ behavior [68], only one study focused on integra-
tion of care [77], but this study focused on case
managers—not physicians—and lacked formal identifica-
tion of barriers and linking of barriers to components. In
a recent review of using theory to plan or evaluate guide-
line implementation among physicians [76], we found no
other studies focusing on guideline adherence that re-
quires integration of care and co-management. This paper
adds value to understand the utility of using such frame-
works when planning integration of care activities across
medical disciplines.
Procedures
We followed the eight steps outlined by the BCW
framework, specifically: (1) define the problem to be
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addressed in behavioral terms; (2) select the target be-
havior(s) most likely to bring about change to address
the problem; (3) specify the target behavior in as much
detail as possible [78]; (4) identify what needs to shift in
order to achieve the target behavior; (5) identify inter-
vention functions; (6) identify policy categories; (7) iden-
tify behavioral change techniques; and (8) identify mode
of delivery. The authors reviewed the detailed guidance
available on how to approach the tasks needed for each
step according to the BCW with reference to the under-
lying evidence [62].
Since a key aspect of the BCW is gleaning infor-
mation from stakeholders, we began our model de-
velopment process by conducting a series of focus groups
to inform each step of the model. The stakeholder focus
groups consisted of 6–8 participants who were either
consumers with severe mental illness, providers, and
healthcare administrators. For the consumer focus group,
we sought to recruit a racial/ethnically diverse sample
reflected the diversity in patients who receive services
from one San Francisco Health Network (SFHN) commu-
nity mental health clinic. The two provider focus groups
consisted of community psychiatrists and six primary care
physicians working in either a SFHN or an SFHN-
affiliated clinic and spent at least 5% of their time treating
adults with SMI. For the administrator focus group, we
invited all directors of primary care outpatient services,
behavioral health outpatient services, pharmacy, and in-
formation technology from SFHN to participate and
provide input on metabolic screenings and treatment.
All subjects provided written informed consent to
participate in the focus group as approved by the
UCSF IRB (12-09789), and all focus groups were
audio-recorded and transcribed for data analysis [79].
To gather data on beliefs and attitudes around the
barriers to metabolic screening and acceptability of
the expansion of psychiatrists’ scope of practice, the
content of the focus group centered on (1) metabolic
screening; (2) treatment of metabolic abnormalities;
and (3) acceptability of potentially expanding the scope of
practice of psychiatrists in community mental health
clinics (see Appendix A for full interview guide).
Data from the focus groups were initially used to
identify relevant TPB domains and constructs in three
areas (attitudes, subjective norms, and perceived
behavioral control) that would influence provider
behavior. Then, for each step of the BCW framework,
two members of the research team were jointly respon-
sible for analyzing, summarizing, and combining focus
group findings, peer-reviewed literature, and their own
clinical experience. Any disagreements were discussed
until consensus was reached. Final decisions were
reviewed by the larger research team and confirmed
by a research community advisory group that in-
cluded a medical director and several psychiatrists
and social workers at one large community mental
health clinic.
Results
Participants
Four focus groups were conducted with each of the
following stakeholder groups: consumers with severe
mental illness (n = 8), psychiatrists (n = 8), primary
care providers (n = 6), and healthcare administrators
(n = 7). Appendix B includes participant demo-
graphic information.
Fig. 1 The Behavior Change Wheel [62]
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Step 1: Define the problem to be addressed in behavioral
terms
Although multiple factors within the healthcare delivery sys-
tem contribute to the poor medical care of people with SMI,
the first step according to the BCW model is to identify a
specific problem and define it in behavioral terms. As out-
lined in the introduction, most of the early morbidity and
mortality among people with SMI is from cardiovascular
disease. Our research team has been focused on improving
detection of cardiometabolic risk and knows the evidence
that less than 30% of patients with SMI receive guideline-
recommended metabolic screenings [80]. Given our prior
research, the specific problem we identified was low meta-
bolic screening in community mental health clinics. We
then defined the behavioral target to be the ordering of an-
nual metabolic screening labs (e.g., hemoglobin A1c and
lipid panel). The BCW requires identification of the per-
formers of the task and the place in which they will be per-
forming the task. Our focus group findings indicated that
community psychiatrists felt responsible for metabolic
screenings [81]. Furthermore, people with SMI use commu-
nity mental health services more often than primary care
services [82], often visit their psychiatrist several times a
year, and some consider community mental health to be this
populations’ medical home [83]. Thus, we specified psychia-
trists as the “performers,” community mental health clinics
as the “place,” and ordering metabolic screening labs for
people with SMI as the “behavioral target.”
Step 2: Select the target behaviors most likely to bring
about change to address the problem
Since behaviors do not occur in isolation but rather in a sys-
tem, a key task was to understand the context of other be-
haviors relevant to the target behavior of psychiatrists
working at community mental health clinics ordering and
managing metabolic screenings. To do this, using data from
the focus groups and our review of the literature, our re-
search team generated a list of potential target behaviors
that addressed the problem of low metabolic screening in
community mental health clinics. This list included en-
gaging patients to be more responsible for their metabolic
screening labs, engaging family members to request screen-
ings, having primary care providers take enhanced responsi-
bility for understanding the metabolic risks, developing a
system-wide metabolic screening effort, and having psychia-
trists assume the role of ordering cardiometabolic labs. Next,
we organized and prioritized all the potential target behav-
iors to determine which behavior was dependent on other
behaviors, which behaviors were relevant to be performed
by the target group and ultimately which behavior or set of
behaviors to intervene. We then used a list of BCW criteria
to estimate the likelihood and promise of each potential tar-
geted behavior. These criteria involved assessing the likely
impact of the behavior change, the likelihood of the change
actually occurring based on the capability, opportunity and
motivation of the target group, the spillover effect of the
behavior change, and the ease of measuring the behavior.
Two members of the research team independently
reviewed the various criteria, and any disagreements were
resolved through discussion and group consensus. The
prioritization process maintained the target behavior
identified in Step 1: Community psychiatrists ordering
annual metabolic labs for their patients with SMI
served in community mental health clinics.
Step 3: Specify the target behavior in as much detail as
possible
In this step, we used specific BCW questions to guide the
development of the process for carrying out the target
behavior:
 Who needs to perform the behavior? Psychiatrists or
nurse practitioners.
 What do they need to do differently to achieve the
desired change? Regularly assess whether patients
are due for annual metabolic screening rather than
defer this to primary care.
 When do they need to do it? When seeing patients
taking antipsychotic medications
 Where do they need to do it? At the community
mental health clinic.
 How often do they need to do it? Annually for each
patient (likely about 10–15 times a month given a
typical caseload for a full-time community
psychiatrist.
 With whom do they need to do it? With all patients
taking antipsychotic medications.
Step 4: What needs to change in order to achieve the
target behavior?
To identify ways to facilitate the targeted behavior change,
this step was aimed at examining the existing situation in
regards to the activities of the performers. While we defined
the problem as low metabolic screening and the behavioral
target as psychiatrists ordering metabolic labs for people
with SMI in community mental health clinics, we had to
specify who would be engaging in this behavior and deter-
mine whether it was feasible for those identified to be com-
pleting the behavior. To understand this, we focused on
responses from the provider focus groups and found that
there were longstanding beliefs around the traditional role
of a psychiatrist working in a community mental health
clinic. We then utilized the TPB framework [65] to organize
our focus group data into attitudes, subjective norms, and
perceived behavioral control issues that might impede the
target behavior (Table 1).
We then applied our findings to the three broad BCW
components to be examined in order to achieve a target
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behavior: (1) capability, (2) opportunity, and (3) motivation
(COM-B) (Fig. 1). The capability component refers to
whether the person or persons identified as carrying out the
targeted behavior change is physically and psychologically
capable (e.g., knowledge, skills, stamina) of doing so. The
opportunity component evaluates whether the behavior is
physically accessible, affordable, socially acceptable, and able
to be accomplished in a reasonable amount of time. The
motivation component is defined as the intellectual pro-
cesses that lead to the behavior change and includes habitual
processes, emotional responses, and decision-making. These
components affect one another. For example, opportunity
can influence motivation as can capability; enacting a behav-
ior can change capability, motivation, and opportunity.
We applied the TDF in this step to integrate relevant the-
oretical constructs to further inform the development of the
current model [62]. Since each domain of the TDF corre-
lates to a COM-B component, using the two together allows
for an expansion of the COM-B components into very spe-
cific domains. Using the COM-B model and the TDF, three
members of the team performed a behavioral diagnosis in
order to determine what needed to change to enable psychi-
atrists in community mental health clinics to improve meta-
bolic screenings among patients with SMI. The information
for this behavioral diagnosis came from focus group find-
ings, peer-reviewed literature, and research team discussion.
A key factor we identified was that while psychiatrists knew
how to order annual labs and had the capability to speak
with their patients about the importance of getting labs, they
felt uncomfortable managing metabolic abnormalities if
these were identified through screening. We also found that
lab slips were not readily available in the treatment rooms,
and that psychiatrists did not have the support resources re-
quired to have these forms pre-completed for them. The be-
havioral diagnosis indicated that in order to achieve the
target behavior of having psychiatrists order metabolic labs,
there was a need for change in psychological capability,
physical and social opportunity, and reflective and automatic
motivation for the target behavior.
Step 5: Identify intervention functions
Having identified the relevant COM-B components related
to physician behavior that needed to change in Step 4, we
explored how to address each of the barriers by focusing on
specific intervention functions. Intervention functions are
categories that more precisely describe routine activities. For
example, “education” can include “training,” but for pur-
poses of facilitating behavior change, it is important to dis-
tinguish between education and training with the former
emphasizing the transfer of knowledge and development of
understanding and the latter emphasizing the building of
skills. We first prioritized the intervention functions based
on the previous organization of behavior change activities
(see Step 4) as any given intervention could in principle per-
form more than one behavior change function. Thus the
intervention categories identified from the 19 existing
Table 1 Utilization of the theory of planned behavior (TPB) to understand barriers to having psychiatrists ordering and managing
metabolic labs (target behavior)
Domains Constructs Barriers to target behavior
Attitudes
Social/professional role
and identity
Identity It’s not my role to manage diabetes if I find an abnormality.
Motivation and goals Goal setting My patients are so sick, diabetes screening is low on the priority list
Beliefs about capabilities Control of behavior and
environment
My patients are too cognitively impaired to make it to the lab
Self-confidence I don’t know how to prescribe medications to treat metabolic abnormalities like
diabetes
Beliefs about
consequences
Outcome expectation What if these medications to treat metabolic abnormalities cause serious adverse
side effects?
Subjective norms
Social influences Social/group norms Nobody else is managing diabetes!
Environmental context
and resources
Resources/materials The electronic systems are separate, so why bother?
My medical director won’t want me to do this because we won’t be able to bill
for the treatment
Perceived behavioral control
Knowledge Knowledge I don’t know exactly what the ADA/APA guidelines recommend
Skills Skills I don’t know how to initiate medications if there are abnormalities
Environmental context
and resources
Resources/materials I don’t have reminders to get the HgA1c.
I can’t access primary care, so why bother?
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frameworks were better conceived of as non-overlapping
functions: a given intervention may involve more than one
of these. Through our focus groups with psychiatrists, we
learned that a many of them wanted to know when labs
were due. We also found that many psychiatrist focus group
participants highlighted the traditional role of psychiatrists
to exclusively manage mental health, and the lack of training
in managing metabolic disorders. Therefore, we explicitly
identified intervention functions that would help support
psychiatrists to know when labs were due and to initiate
medications to treat metabolic disordered identified as a re-
sult of increased metabolic screening. Similarly, we needed
to differentiate training from “modeling.” In common prac-
tice, modeling is a method used in training, but we use the
term more specifically to refer to imitation of an authority
figure as a motivational driver since some focus group par-
ticipants voiced concern about expanding their scope of
practice. A third example is the use of the term “enable-
ment.” In everyday use, this could include most of the other
intervention categories, but here the term refers to forms
of enablement that are either more encompassing (as in,
for example, ‘behavioral support’ for medication manage-
ment) or work through other tools (as in, for example,
physical and Internet-based decision support aids to pro-
vide guidance on medication dosage for specific cardio-
metabolic disorders).
Table 2 outlines different potential intervention functions
associated with the corresponding COM-B components
identified in Step 4 to facilitate the target behavior. For
example, psychiatry focus group participants identified lack
of reminders as a barrier to ordering labs for patients with
SMI. From an intervention development perspective, this
issue was understood as a barrier related to the ‘environ-
mental context and resources’ for psychiatrists in having to
navigate a new process in an already busy setting (capability
and opportunity). We then selected intervention functions
to help psychiatrists or other staff overcome the barriers that
were most pertinent to ordering metabolic labs. Two mem-
bers of the research team evaluated whether these
interventions met BCW APEASE criteria (affordable, prac-
ticable, effective and cost effective, acceptable, safe, and
equitable) to maximize capability, opportunity, and motiv-
ation to achieve the desired behavior change. For example,
pre-completed lab slips (environmental restructuring) was
selected because it met all APEASE criteria.
Step 6: Identify policy categories
After developing the intervention strategy, we evaluated
what policies will support the delivery of the intervention
functions in this step. Seven policy categories to help sup-
port and enact the interventions were considered, including
communication/marketing, guidelines, fiscal measure, regu-
lations, legislation, environmental/social planning, and ser-
vice provision. We identified which of the seven policy
categories were most applicable to the identified interven-
tion function (Table 3). For example, we decided to brand
the intervention by creating a logo and placing it on printed
decision charts to create a culture change and used branded
mugs and birthday cards to staff members as persuasion.
Step 7: Identify behavioral change techniques
After selecting the intervention functions and policy
categories that might help deliver the intervention, we
identified behavioral change techniques to develop the
final model. A behavioral change technique is defined as
“an active component of an intervention designed to
change behavior” [62]. The techniques are active ingredi-
ents within the intervention and leads to observable and
replicable behavior change. Two members of the research
team jointly determined the following behavioral change
techniques most relevant for this model based on the
results of the focus groups from the stakeholder inter-
views and then independently reviewed by research team
members and ultimately agreed upon in a group con-
sensus. Furthermore, the following identified behavior
change techniques are thought best to serve the pre-
viously identified intervention functions that were
linked to the BCW components:
– Additional resources: psychiatrists would need
additional resources to ease the process of ordering
metabolic labs, specifically a monthly registry of
patients who are due for screening labs and pre-
completed laboratory slips.
– Social support: two new team members will provide
social support: (1) peer navigator to help complete lab
slips, assist patients to phlebotomy services, and enter
data into the electronic medical record, and (2) a
primary care consultant to help provide clinical
decision support for psychiatrists initiating medications
to treat metabolic abnormalities.
– Goal setting: regular performance monitoring will
help ensure that 80% of all patients receive annual
metabolic screening.
– Problem solving: psychiatrists will have immediate
electronic access to a primary care consultant to
provide clinical decision support.
– Action planning: algorithms help provide psychiatrists
with a plan for any abnormal values identified on
screening metabolic labs.
– Self-monitoring: performance monitoring of
metabolic screening status on the panel of each
individual psychiatrists.
– Review of behavior and outcome goals: conduct a
quarterly panel review for all patients with labs due
over a three-month period to troubleshoot complex
cases and to receive feedback from psychiatrists and
ancillary staff on the intervention.
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Table 2 Behavioral diagnosis and intervention functions to address change in the COM-B categories among providers and staff
COM-B
component
Theoretical
domains and constructs
What needs to happen for
the target behavior to occur?
Potential candidate
intervention functions
Potential behavioral targets
(responsible staff)
Physical
capability
Skills Physical skills to prepare lab slips Not applicable None: psychiatrists have physical skills to
prepare and distribute lab slips.
Physical skills to distribute lab slips
Environmental context
and resources
Lab slips need to be readily available Environmental
restructuring
Make sure lab slips are fully stocked in all
treatments rooms (clinic staff).
Psychiatrists must have access to
all relevant laboratory data from
the different systems in which
they are served
Creation of a registry with laboratory data
from several electronic records (clinic staff).
Psychological
capability
Knowledge Psychiatrists need to know and
can easily learn what specific
metabolic labs to order
Education Education about metabolic screening
guidelines (primary care consultant).
Education about medications
(and side effects) to treat potential
metabolic abnormalities
(primary care consultant).
Persuasion Using colorful and readable visual charts to
motivate learning the cutoffs for different
normal cardiometabolic levels (primary care
consultant creates; clinic staff distributes).
Psychiatrists need to know how
to initiate treatment when metabolic
abnormalities are identified
Training Receive instruction on how to read and use
the decision charts with algorithms in making
treatment decisions (primary care consultant).
Memory Psychiatrists need to remember
the algorithms for treatment
Enablement Making algorithm decision charts readily
available by distributing copies to all
psychiatrists, posting copies in all treatment
rooms, and making it accessible electronically
(primary care consultant creates; clinic staff
distributes).
Attention and decision
processes
Psychiatrists need to have support
for treatment decisions
Environmental
restructuring
Providing access to a primary care consultant
for clinical decision support through the
electronic medical record (EMR) system
(IT administrator).
Social role and identity Psychiatrists need to believe that
it is their role to screen and treat
metabolic abnormalities.
Modeling Medical director participates in trainings and
uses algorithms and primary care consultant
via EMR system for decision support around
managing cardiometabolic lab results (clinic
medical director).
Physical
opportunity
Intentions and goals Patients need to receive filled
out lab slips from psychiatrists.
Enablement Provide psychiatrists with completed lab slips
monthly for patients with labs due and
samples of completed lab slips in examination
rooms; ensure that examination rooms are
fully stocked with lab slips (clinic staff).
Utilize phlebotomy services
that are located near clinic.
Persuasion Distribute map of identified lab screening
locations and transportation route to all
patients with labs due to increase motivation
to follow through on obtaining labs
(clinic staff).
Patients who are disorganized or
have physical disabilities should
receive assistance to obtain
phlebotomy services
Environmental
restructuring
Ensure the availability of a peer navigator as
a physical resource for assistance with patients
that require assistance in obtaining labs
(peer navigator).
Social
opportunity
Social influences Staff psychiatrists observe
senior health providers ordering
and managing metabolic labs.
Modeling Local clinic medical director participates
in and helps with designing the intervention
(clinic medical director).
Psychiatrists need support to
manage abnormalities and
access to primary care services
Enablement The intervention has the support of local
champions and leadershipin the form of
additional resources that aid psychiatrists in
managing cardiometabolic labs
(clinic medical director).
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To achieve the targeted behavior change of having
psychiatrists order labs and to manage metabolic
abnormalities, it was critical to provide them with support
and the information they needed to do the task, and the
expected health consequences of not making this the
behavior change. In addition, having regular and timely
feedback sessions on the outcomes of the behavior lead to
self-monitoring, problem-solving, and further action
planning.
Step 8: Identify mode of delivery
In specifying the behavioral change techniques and focusing
on psychiatrist behavior, we then identified potential modes
of delivering the intervention and created an integration of
care model that we called CRANIUM (cardiometabolic risk
assessment and treatment through a novel Integration
model for underserved populations with mental illness).
CRANIUM is comprised of four components: patient-
centered team care (psychiatrist, case manager, primary
care provider, and peer navigator), population-based care
(patient registry), screening protocols (HgA1c, LDL, SBP,
DBP), and treatment protocols (guideline-recommended
pharmacological management for diabetes, hypertension,
and dyslipidemia) (Fig. 2). In addition to the member of a
usual community mental health care team (psychiatrist and
care manager), the new patient-centered team includes a
primary care consultant and a peer navigator. Because pa-
tients with mental illness receive their primary care from
various health care settings—and laboratory data are not
integrated with the behavioral health EMR, we had to
Table 2 Behavioral diagnosis and intervention functions to address change in the COM-B categories among providers and staff
(Continued)
COM-B
component
Theoretical
domains and constructs
What needs to happen for
the target behavior to occur?
Potential candidate
intervention functions
Potential behavioral targets
(responsible staff)
Reflective
motivation
Optimism Psychiatrists need to believe that
regular metabolic lab screening and
treatment will lead to better care
Education Provide education about improved health
outcomes after screening and treatment,
and give examples from prior studies to
show that it is possible for patients with
SMI to have metabolic labs managed in
community mental health settings
(primary care provider).
Beliefs about
consequences
Psychiatrists need to believe that
their work will decrease mortality
rates among this population
Persuasion
Automatic
motivation
Reinforcement Need an established routine for
reminding psychiatrists about
labs and providing feedback for
following through on labs.
Enablement Automated system for reminding psychiatrists
which patients have labs due (IT administrator).
Incentivization Provide regular performance monitoring
to show proportion of patients for each
provider that receive lab draws over time
and reward providers in their efforts to
order lab draws in their patients
(IT administrator)
Education Provide information regarding improved
health outcomes for patient population
(primary care consultant).
Table 3 Policy categories for the CRANIUM collaborative care model
Intervention function Policy category Candidate policies to support the delivery of the intervention functions
Education Guidelines Treatment protocols for management of metabolic disorders were distributed
(on-line and laminated).
Persuasion Communication/marketing Mugs and birthday cards with logo for clinic staff; logo on algorithms
Incentivization Fiscal measures Treats (e.g., cookies) were provided to the team with the highest metabolic screening rates.
Coercion Service provision Treatment teams knew which teams were the “best” and might be coerced to compete
Training Guidelines A primary care physician reviewed guidelines and protocols for management of
metabolic disorders.
Service provision Established a support service of a primary care consultant for psychiatrists to access on-line
Environmental restructuring Environmental/social
planning
Restructuring the clinic to include in pre-completed lab slips in all interview rooms.
Stepped care approach where peer navigators could assist patients in going to
phlebotomy services.
Modeling Service provision Medical Director adopts behavior change and becomes the champion and role model for
other staff.
Enablement Environmental/social
planning
Changing roles where psychiatrist can safely initiate treatment of common
metabolic abnormalities.
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identify a means to provide this information to their
patient-centered team. As such, electronic registry that
consolidates information from multiple electronic medical
records (EMRs) was developed which had pertinent la-
boratory and vital sign data. Psychiatrists received this
monthly registry containing annual metabolic screening
results on all of their patients. Although registries like this
are common in primary care, having easily accessible,
electronic, and timely laboratory data on health monitor-
ing is a rarity in public mental health care systems [84]. A
quarterly panel management meeting was proposed to
focus on of patients who are missing screening labs and to
develop individualized support plans based on screening
protocols. Among those with identified cardiometabolic
risk factor abnormalities, treatment protocols with deci-
sion support tools were developed. These protocols in-
clude reminders to encourage smoking cessation, obesity
care, and offer evidence-based pharmacologic treatment
for identified CVD risk factor abnormalities.
Discussion
By using the results from application of the BCW frame-
work, we were able to systematically design an integration
of care model to increase screening and initial treatment of
CVD risk factors in people with SMI that was grounded in
behavior change theory. We used both provider-level and
system-level targets to build this model (Fig. 3).
The model that emerged was an integrated and patient-
centered care model to improve healthcare delivery for
individuals with SMI and incorporates principles from the
several prior models [85–88]. The model was called CRA-
NIUM. The CRANIUM intervention includes elements of
patient-centered team care, population-based care, screening
protocols, and evidence-based treatment protocols. This
model utilized several BCW intervention functions (e.g., en-
vironmental restructuring, education, training, enabling, and
modeling) to address the cultural shift required to change
the behavior of community psychiatrists. The template for
intervention description and replication (TIDieR) checklist
[89] was used to describe specific components of the inter-
vention (Appendix C).
CRANIUM bears the most similarity to the evidence-
based Collaborative Care model that is based in primary
care settings [90]. Since 40% of people with SMI regularly
access community mental health services [91] and these set-
tings are de-facto health home for these patients, CRA-
NIUM attempted to resolve a systemic problem by
leveraging technology to enable community psychiatrists to
take a more active role in screening and initial management
of metabolic disorders. Utilizing psychiatrists to take on this
role represents a significant culture shift, and also requires a
complex system change to alleviate structural dysfunctions
between mental health and primary care. Utilizing the BCW
framework, we were able to develop a model that has a
strong foundation in behavioral theory and hopefully will be
highly acceptable to end-users.
The process of developing CRANIUM included many
strengths. First, the use of the BCW and TDF frameworks
are heavily grounded in behavior change theory and linked
to evidence-based intervention functions that can orient an
intervention to a targeted setting and population. As men-
tioned previously, only one other study focused on integra-
tion of care in a recent systematic review of changing
healthcare professionals’ behavior [68], with ours being the
only to formally identify and link barriers to integration of
care to specific intervention components. Second, by using
the BCW framework to defined the behavioral target to
address the specific problem of low adherence to national
guidelines for metabolic screening [4], our model is the first
to focus on guideline adherence that requires integration of
care and co-management by physicians [76]. As such, this
paper adds significant value to use of such behavioral
frameworks when planning integration of care activities
across medical disciplines.
Finally, the use of feedback from multidisciplinary staff
in quarterly meeting during the course of the interven-
tion design was a unique way to maximize community
engagement.
Fig. 2 CRANIUM intervention components
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However, there are limitations to using these approaches
[92], for example, they require a lengthy barrier identifica-
tion and intervention planning process, and it is often not
possible to address all of the barriers and potential enablers
identified, making it difficult to actualize all of the compo-
nents that can aid in addressing the behaviors required to
make multi-level changes. Alternatively, we could have ap-
plied other implementation science frameworks such as
CFIR or RE-AIM [93, 94]. These might have been helpful
to place/map the intervention into the context of clinic or
community settings, but would not have provided the same
level of focus on behavior change which we believed was
critical for this problem. Another limitation is that the over-
all approach was primarily aimed at targeting the individual
health care provider, but did not necessarily focus on case
management teams or the larger public health system.
Conclusions
Individuals with SMI experience a highly fragmented
system of care, contributing to poor health outcomes. The
utilization of the Behavior Change Wheel Framework
enabled a systematic and theory-driven approach to be
taken to the development of a behavior change intervention
within clinical practice for the management of metabolic
disorders by community psychiatrists. To our knowledge,
no one has used this framework to develop an intervention
to improve the health of people with severe mental illness
in community mental health clinics. Public health adminis-
trators might consider using these systematic frameworks
in addressing some of their most complex systems-level
problems. In our opinion, this framework proved to be a
practical way of using theory to inform the development of
an evidence-based integration of care solution that may re-
sult in significant public health implications.
Appendix A
Guiding questions for focus groups
For all focus groups
 Describe any barriers that might prevent people
with mental illness from receiving annual screening
for metabolic disorders.
 Describe any barriers people with severe mental
illness might have in getting “medical” medications
(e.g., prescribing a statin for high cholesterol).
 Are there any barriers that might be specific to
racial or ethnic minority populations?
 What would you think about psychiatrists providing
these medical medications if they had the support of
a “virtual” (email) primary care physician (PCP)
consultant?
 What are your concerns about having a virtual
primary care consultant being used to facilitate
treatment of high cholesterol by psychiatrists?
 What are your thoughts about having pre-made
algorithms for common disorders (e.g., high
cholesterol) for psychiatrists to use?
For provider focus groups only
 Please describe your current practices for
metabolic screening and treatment of metabolic
abnormalities.
For patient focus groups only
 Have you been treated for metabolic complications by
your psychiatrist? If so, which one (blood pressure,
diabetes, dyslipidemia)?
Fig. 3 CRANIUM targets to improve cardiometabolic screening and treatment in community mental health clinics
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Appendix B
Appendix C
Table 5 The TIDieR (template for intervention description and replication) checklist
Item
#
Item Where located
Primary paper
page
Other
1 Brief name: CRANIUM (cardiometabolic risk assessment and treatment through
a novel integration model for underserved populations with mental illness).
The CRANIUM intervention includes the following elements: patient-centered
team care, population based care, screening protocols and evidence-based
treatment protocols.
Page 15 http://cranium.ucsf.edu/
2 Why: changing the behavior of community psychiatrists to initiate treatment
of cardiometabolic risk factors was essential for the success of this intervention.
As such, we relied heavily on several theoretical framework to develop the
intervention (The Behavior Change Wheel, Theoretical Domains Framework,
and the theory of planned behavior). We also addressed organizational-level
factors that could facilitate the behavior change.
Pages 5–7,
Fig. 3
3 What (material):
3a. Patient-centered team-care: each team was provided with roles/
responsibilities of each team member.
3b. Population-based care: a patient registry and pre-completed lab
slips were provided to teams.
3c. Screening protocols: we based our screening protocols on the 2004
APA/ADA guidelines.
3d. Evidence-based treatment protocols: protocols were placed in
all treatment rooms and provided electroinically to psychiatrists.
Pages 13–14
and Fig. 2
3a. http://tinyurl.com/ydarwyry
3b. http://tinyurl.com/y9cjatjd
3c. https://www.ncbi.nlm.nih.gov/
pubmed/14747245
3d. http://tinyurl.com/y9fxwg8v
4 What (procedures):
4a. Patient-centered team-care: all team members meet quarterly to
discuss patients. The ePCP is also available for as needed questions online
4b. Population-based care: psychiatrists and case managers received monthly
registries on metabolic screening of their patient panels.
4c. Screening protocols: psychiatrists receive a lecture on screening protocols.
All team members reviewed patients missing labs at quarterly panel
management meetings
4d. Evidence-based treatment protocols: all psychiatrists received a 1× lecture on
treatment and discussed patients needing treatment at the quarterly panel
management meetings.
Page 14–15 4c and 4d. http://cranium.ucsf.edu/
article/tools-clinicans
5 Who provided: the psychiatrists receieved a 1× training on treatment of
cardiometabolic risk factors by the primary care consultant. The case manager
and peer navigator were taught about panel management.
Page 13–15 http://tinyurl.com/ydarwyry
https://youtu.be/v1G4BuklmbA
Table 4 Focus group participant demographic information
All participants (n = 29) Psychiatrists (n = 8) Primary care
(n = 6)
Administrators
(n = 7)
Consumers
(n = 8)
Age in years, mean (range) 46.6 (28–67) 44.5 (35–67) 44.8 (32–52) 49.1 (41–58) 48 (range 28–65)
Sex
Male 14 (48.3%) 3 (37.5%) 2 (33.3%) 3 (43%) 6 (75.0%)
Female 5 (51.7%) 5 (62.5%) 4 (66.7%) 4 (57.1%) 2 (25.0%)
Race
African American 3 (10.3%) 1 (12.5%) 0 (0%) 0 (0%) 2 (25.0%)
Latino 5 (17.2%) 0 (0%) 0 (0%) 2 (28.6%) 3 (37.5%)
White 13 (44.8%) 6 (75.0%) 2 (33.3%) 2 (28.6%) 3 (37.5%)
Asian 7 (24.1%) 1 (12.5%) 3 (50.0%) 3 (42.9%) 0 (0%)
Native American 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Other/multiracial 1 (3.4%) 0 (0%) 1 (16.7%) 0 (0%) 0 (0%)
Years worked in health or mental health, mean
(range)
n/a 12.9 (4–30) 15.3 (3–25) 23.6 (17–33) n/a
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#
Item Where located
Primary paper
page
Other
6 How: the training of psychiatrists on treatment of carediometabolic risk factors
was online and/or in person. The panel management meetings were in-person,
group meetings. The support from the primary care consultant was individual and
delievered electronically, on the phone, or in-person.
Page 13–15 http://cranium.ucsf.edu/article/
tools-clinicans
7 Where: the intervention itself occurred in the community mental health clinic. The
panel management meetings happened quarterly in a clinic conference room
Page 10
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missing labs and/or needing treatment (4c).
4b. Population-based care: psychiatrists and case managers received monthly registries
on metabolic screening of their patient panels. All team members reviewed patients
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4d. Evidence-based treatment protocols: all psychiatrists received a one-time lecture on
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Page 13–14
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administrators. We do not currently know what additional tailoring might be avialble
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Page 8
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